Cancer Monoclonal Antibodies Global Market Report 2020-30: COVID-19 Growth and Change - Press Release digitaljournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitaljournal.com Daily Mail and Mail on Sunday newspapers.
Significant Leadership Changes Announced Across Several Commercial Real Estate Firms
CBRE expands office investor leasing group with former Cushman & Wakefield team, Trammell Crow Co. promotes three to C-Suite, and more.
The Dallas-Fort Worth commercial real estate industry has seen major activity in the past couple of weeks but I am not talking about deals and transactions.
Earlier this week, news broke that 30-year industry veteran Ran Holman departed his position at Cushman & Wakefield to oversee the newly rebranded Newmark’s growing presence in Dallas-Fort Worth, Houston, Austin, San Antonio, and other markets (click here to read more). The news was followed by the sudden departure of Steve Everbach from Colliers International and the naming of former CBRE executive Daniel Taylor as executive managing director and market leader of Colliers’ Dallas office (click here to read more).
New Drug Improves Survival in Acute Lymphoblastic Leukemia by Pooja Shete on December 10, 2020 at 1:23 PM
When first-line chemotherapy regimen was combined with monoclonal antibody blinatumomab in a newly diagnosed high-risk form of acute lymphoblastic leukemia (ALL) known as Philadelphia chromosome-negative B-cell ALL (Ph-negative B-ALL), an increase in survival and a high rate of negative measurable residual disease (MRD) were seen in patients.
The measurable residual disease is an independent, post-diagnosis indicator to determine the course of the disease and treatment plan for acute myeloid leukemia.
The study was led by the University of Texas MD Anderson Cancer Center and was presented at Annual Meeting of the American Society of Hematology. The study was led by Elias Jabbour MD professor of leukemia and was presented by Nicholas Short MD, assistant professor of leukemia.